It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

24th January 2024 @ 11am ET

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle. 

Real-world data (RWD) and evidence (RWE) can add new and supplementary insights on the performance of medical devices outside of the rigorously controlled confines of clinical trials. Additionally, the longitudinal nature of much of this data can provide greater insights into the safety and longer-term needs of patients. Furthermore, real-world data can support evidence on the fit-for-purposeness across additional use cases, not studied in early trials. Data collected in a real-world setting can serve to initiate a feedback loop, whereby providers and hospitals receive evidence that can serve to improve clinical practice. 

Join this roundtable in collaboration with S3 Connected Health, for which we will delve into three specific phases of the lifecycle and explore pragmatic considerations on leveraging RWD/RWE most effectively:

  • Regulatory Approval: What types of real-world data are available for medical devices, and how can they be leveraged to improve patient outcomes?
  • Market access: How can real-world data/evidence be used to support health technology assessment (HTA) and market access for medical devices, and what are the key considerations for payers and providers?
  • Adoption and implementation: How can real-world evidence be used to support the adoption of medical devices by patients and integration into clinical workflows, and what are the key challenges and opportunities?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
Blaise Jacholkowski
Senior Business Solution Manager / Digital Health, Zuhlke Group
Apply to Attend

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

24th January 2024 @ 11am ET

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle. 

Real-world data (RWD) and evidence (RWE) can add new and supplementary insights on the performance of medical devices outside of the rigorously controlled confines of clinical trials. Additionally, the longitudinal nature of much of this data can provide greater insights into the safety and longer-term needs of patients. Furthermore, real-world data can support evidence on the fit-for-purposeness across additional use cases, not studied in early trials. Data collected in a real-world setting can serve to initiate a feedback loop, whereby providers and hospitals receive evidence that can serve to improve clinical practice. 

Join this roundtable in collaboration with S3 Connected Health, for which we will delve into three specific phases of the lifecycle and explore pragmatic considerations on leveraging RWD/RWE most effectively:

  • Regulatory Approval: What types of real-world data are available for medical devices, and how can they be leveraged to improve patient outcomes?
  • Market access: How can real-world data/evidence be used to support health technology assessment (HTA) and market access for medical devices, and what are the key considerations for payers and providers?
  • Adoption and implementation: How can real-world evidence be used to support the adoption of medical devices by patients and integration into clinical workflows, and what are the key challenges and opportunities?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to AttendRegister to AttendApply to Attend

Participants

Participants

Piotr Sokolowski

Head of Strategy, MedTech Solutions at S3 Connected Health

Blaise Jacholkowski

Senior Business Solution Manager / Digital Health, Zuhlke Group

Marko de Jager

Principal Scientist, Philips Ambulatory Monitoring & Diagnostics

Friedrich Wetterling

Data Science and Research Manager, FIRE1

Frances Mitchell

Director, Innovation Strategy and Insight, Teleflex

Tiffany Naidoo

Senior HEMA Manager, BIOTRONIK

Ventsislav Dobrev

Global Innovation & Digital Health Solutions Manager, Ypsomed

Yash Prajapati

Consultant, zs

Kathleen Van Vlierberghe

Vice President Healthcare Solutions & Partnerships EMEA, Boston Scientific

Aghogho Ekpruke

Innovation Leader, MedTech Architect, Medtronic

Gurdish Singh

Portfolio Asset Lead, Boehringer Ingelheim

Marc Blanchard

Chief Development Officer - CDO at ATREON SA

Abdul Khaled

Senior Director - Digital Solutions, WS Audiology

Anupama Govindarajan

Sr. Advisor to Digital Health FDA / Program Officer NIH

Sujai Kalra

Director, Analytics & Integrations, Nevro

Bradley Carlson

Consultant, Independent

Mike Pace

CEO & Founder, PalmHealth.co

Weronika Michaluk

Principal , HTD Health

Sandra Nagale

Director - Digital Health & Data Solutions, Boston Scientific

Bill Betten

Director of Solutions, S3 Connected Health

Brenna Beluk

Product Manager, Digital Health, Consultant, Boston Scientific

Number of Participants


Up to 12
Date  
January 24, 2024
Community

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle. 

Real-world data (RWD) and evidence (RWE) can add new and supplementary insights on the performance of medical devices outside of the rigorously controlled confines of clinical trials. Additionally, the longitudinal nature of much of this data can provide greater insights into the safety and longer-term needs of patients. Furthermore, real-world data can support evidence on the fit-for-purposeness across additional use cases, not studied in early trials. Data collected in a real-world setting can serve to initiate a feedback loop, whereby providers and hospitals receive evidence that can serve to improve clinical practice. 

Join this roundtable in collaboration with S3 Connected Health, for which we will delve into three specific phases of the lifecycle and explore pragmatic considerations on leveraging RWD/RWE most effectively:

  • Regulatory Approval: What types of real-world data are available for medical devices, and how can they be leveraged to improve patient outcomes?
  • Market access: How can real-world data/evidence be used to support health technology assessment (HTA) and market access for medical devices, and what are the key considerations for payers and providers?
  • Adoption and implementation: How can real-world evidence be used to support the adoption of medical devices by patients and integration into clinical workflows, and what are the key challenges and opportunities?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participate in the Meeting

HealthXL Roundtables

HealthXL community meetings connect senior leaders from around the world.

Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.

Participant-Led

HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.

Developed for a Busy Schedule

At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Masterclasses

HealthXL community events give unparalleled access to digital health leaders from around the world.

Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.

EXPERT-Led

HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Webinars

HealthXL community events give unparalleled access to digital health experts from around the world.

Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.

Expert Panel Discussion

Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports
Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Events
April 2, 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: March 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: March 2024
Read More
Events
March 13, 2024
#ViVE2024 Unwrapped: Highlights and Insights
#ViVE2024 Unwrapped: Highlights and Insights
Read More
Commentary
February 16, 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Read More

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

24th January 2024 @ 11am ET

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

24th January 2024 @ 11am ET
Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
LinkedIn Profile
Blaise Jacholkowski
Senior Business Solution Manager / Digital Health, Zuhlke Group
LinkedIn Profile
Marko de Jager
Principal Scientist, Philips Ambulatory Monitoring & Diagnostics
LinkedIn Profile
Friedrich Wetterling
Data Science and Research Manager, FIRE1
LinkedIn Profile
Frances Mitchell
Director, Innovation Strategy and Insight, Teleflex
LinkedIn Profile
Tiffany Naidoo
Senior HEMA Manager, BIOTRONIK
LinkedIn Profile
Ventsislav Dobrev
Global Innovation & Digital Health Solutions Manager, Ypsomed
LinkedIn Profile
Yash Prajapati
Consultant, zs
LinkedIn Profile
Kathleen Van Vlierberghe
Vice President Healthcare Solutions & Partnerships EMEA, Boston Scientific
LinkedIn Profile
Aghogho Ekpruke
Innovation Leader, MedTech Architect, Medtronic
LinkedIn Profile
Gurdish Singh
Portfolio Asset Lead, Boehringer Ingelheim
LinkedIn Profile
Marc Blanchard
Chief Development Officer - CDO at ATREON SA
LinkedIn Profile
Abdul Khaled
Senior Director - Digital Solutions, WS Audiology
LinkedIn Profile
Anupama Govindarajan
Sr. Advisor to Digital Health FDA / Program Officer NIH
LinkedIn Profile
Sujai Kalra
Director, Analytics & Integrations, Nevro
LinkedIn Profile
Bradley Carlson
Consultant, Independent
LinkedIn Profile
Mike Pace
CEO & Founder, PalmHealth.co
LinkedIn Profile
Weronika Michaluk
Principal , HTD Health
LinkedIn Profile
Sandra Nagale
Director - Digital Health & Data Solutions, Boston Scientific
LinkedIn Profile
Bill Betten
Director of Solutions, S3 Connected Health
LinkedIn Profile
Brenna Beluk
Product Manager, Digital Health, Consultant, Boston Scientific
LinkedIn Profile

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle. 

Real-world data (RWD) and evidence (RWE) can add new and supplementary insights on the performance of medical devices outside of the rigorously controlled confines of clinical trials. Additionally, the longitudinal nature of much of this data can provide greater insights into the safety and longer-term needs of patients. Furthermore, real-world data can support evidence on the fit-for-purposeness across additional use cases, not studied in early trials. Data collected in a real-world setting can serve to initiate a feedback loop, whereby providers and hospitals receive evidence that can serve to improve clinical practice. 

Join this roundtable in collaboration with S3 Connected Health, for which we will delve into three specific phases of the lifecycle and explore pragmatic considerations on leveraging RWD/RWE most effectively:

  • Regulatory Approval: What types of real-world data are available for medical devices, and how can they be leveraged to improve patient outcomes?
  • Market access: How can real-world data/evidence be used to support health technology assessment (HTA) and market access for medical devices, and what are the key considerations for payers and providers?
  • Adoption and implementation: How can real-world evidence be used to support the adoption of medical devices by patients and integration into clinical workflows, and what are the key challenges and opportunities?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

When:
24th January 2024 @ 11am ET
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.